• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从一名早发性帕金森病患者中重编程得到的人诱导多能干细胞(iPSC)系(IBMSi012-A),该患者在PLA2G6基因中存在纯合的p.D331Y突变。

Reprogramming of a human induced pluripotent stem cell (iPSC) line (IBMSi012-A) from an early-onset Parkinson's disease patient harboring a homozygous p.D331Y mutation in the PLA2G6 gene.

作者信息

Cheng Yu-Che, Lin Han-I, Syu Shih-Han, Lu Huai-En, Huang Ching-Ying, Lin Chin-Hsien, Hsieh Patrick C H

机构信息

Institute of Biomedical Science, Academia Sinica, Taipei, Taiwan.

Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan; Institute of Molecular Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.

出版信息

Stem Cell Res. 2019 May;37:101432. doi: 10.1016/j.scr.2019.101432. Epub 2019 Apr 5.

DOI:10.1016/j.scr.2019.101432
PMID:30978640
Abstract

A recessive mutation in PLA2G6, which is known to cause a heterogeneous neurodegenerative clinical spectrum, has recently been shown to be responsible for autosomal-recessive familial forms of Parkinson's disease (PD). Here, we generated induced pluripotent stem cells (iPSCs) from the peripheral blood mononuclear cells of a female patient with a homozygous PLA2G6 c.991G > T (p.D331Y) mutation by using the Sendai-virus delivery system. The resulting iPSCs showed pluripotency confirmed by immunofluorescent staining for pluripotency markers and differentiated into the 3 germ layers in vivo. This cellular model will provide a good resource for further pathophysiological studies of PD.

摘要

PLA2G6基因中的隐性突变已知会导致多种神经退行性临床症状,最近已被证明是常染色体隐性家族性帕金森病(PD)的病因。在此,我们使用仙台病毒递送系统,从一名患有纯合PLA2G6基因c.991G > T(p.D331Y)突变的女性患者的外周血单个核细胞中生成了诱导多能干细胞(iPSC)。通过对多能性标志物进行免疫荧光染色证实,所产生的iPSC具有多能性,并在体内分化为三个胚层。该细胞模型将为PD的进一步病理生理学研究提供良好资源。

相似文献

1
Reprogramming of a human induced pluripotent stem cell (iPSC) line (IBMSi012-A) from an early-onset Parkinson's disease patient harboring a homozygous p.D331Y mutation in the PLA2G6 gene.从一名早发性帕金森病患者中重编程得到的人诱导多能干细胞(iPSC)系(IBMSi012-A),该患者在PLA2G6基因中存在纯合的p.D331Y突变。
Stem Cell Res. 2019 May;37:101432. doi: 10.1016/j.scr.2019.101432. Epub 2019 Apr 5.
2
Generation of induced pluripotent stem cells (IBMSi011-A) from a patient with Parkinson's disease carrying LRRK2 p.I1371V mutation.从携带LRRK2 p.I1371V突变的帕金森病患者中生成诱导多能干细胞(IBMSi011-A)。
Stem Cell Res. 2019 May;37:101447. doi: 10.1016/j.scr.2019.101447. Epub 2019 Apr 22.
3
Generation of induced pluripotent stem cells from a young-onset Parkinson's disease patient carrying the compound heterozygous PLA2G6 p.D331Y/p.M358IfsX mutations.从一名携带复合杂合PLA2G6 p.D331Y/p.M358IfsX突变的早发性帕金森病患者中诱导产生多能干细胞。
Stem Cell Res. 2019 Oct;40:101552. doi: 10.1016/j.scr.2019.101552. Epub 2019 Aug 27.
4
Reprogramming of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient with a R1628P variant in the LRRK2 gene.从一名携带LRRK2基因R1628P变体的帕金森病患者身上重编程出的人类诱导多能干细胞(iPSC)系。
Stem Cell Res. 2017 Jan;18:45-47. doi: 10.1016/j.scr.2016.12.011. Epub 2016 Dec 10.
5
Development of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient carrying the N551K variant in LRRK2 gene.从一名携带LRRK2基因N551K变体的帕金森病患者身上开发人诱导多能干细胞(iPSC)系。
Stem Cell Res. 2017 Jan;18:51-53. doi: 10.1016/j.scr.2016.12.013. Epub 2016 Dec 8.
6
Generation of a human induced pluripotent stem cell (iPSC) line carrying the Parkinson's disease linked LRRK2 variant S1647T.携带与帕金森病相关的LRRK2变异体S1647T的人诱导多能干细胞(iPSC)系的产生。
Stem Cell Res. 2017 Jan;18:54-56. doi: 10.1016/j.scr.2016.12.010. Epub 2016 Dec 9.
7
Derivation of human induced pluripotent stem cell (iPSC) line with LRRK2 gene R1398H variant in Parkinson's disease.帕金森病中携带LRRK2基因R1398H变异的人诱导多能干细胞(iPSC)系的衍生
Stem Cell Res. 2017 Jan;18:48-50. doi: 10.1016/j.scr.2016.12.014. Epub 2016 Dec 9.
8
PARK14 (D331Y) PLA2G6 Causes Early-Onset Degeneration of Substantia Nigra Dopaminergic Neurons by Inducing Mitochondrial Dysfunction, ER Stress, Mitophagy Impairment and Transcriptional Dysregulation in a Knockin Mouse Model.PARK14(D331Y)PLA2G6 通过诱导线粒体功能障碍、内质网应激、自噬受损和转录失调,在 knockin 小鼠模型中导致黑质多巴胺能神经元的早发性退化。
Mol Neurobiol. 2019 Jun;56(6):3835-3853. doi: 10.1007/s12035-018-1118-5. Epub 2018 Aug 8.
9
GENYOi004-A: An induced pluripotent stem cells (iPSCs) line generated from a patient with autism-related ADNP syndrome carrying a pTyr719* mutation.GENYOi004-A:一种诱导多能干细胞(iPSC)系,由一名患有与自闭症相关的ADNP综合征且携带pTyr719*突变的患者产生。
Stem Cell Res. 2019 May;37:101446. doi: 10.1016/j.scr.2019.101446. Epub 2019 Apr 22.
10
Generation of induced pluripotent stem cell line LNDWCHi001-A from a patient with early-onset Parkinson's disease carrying the homozygous c.1898C > T (p. A633V) mutation in the PLA2G6 gene.从一名早发性帕金森病患者中生成携带PLA2G6基因纯合c.1898C>T(p.A633V)突变的诱导多能干细胞系LNDWCHi001-A。
Stem Cell Res. 2024 Mar;75:103305. doi: 10.1016/j.scr.2024.103305. Epub 2024 Jan 8.

引用本文的文献

1
Infantile neuroaxonal dystrophy: Molecular mechanisms and pathogenesis of PLA2G6-associated neurodegeneration.婴儿神经轴索性营养不良:与PLA2G6相关神经变性的分子机制和发病机制
AIMS Neurosci. 2025 May 30;12(2):180-202. doi: 10.3934/Neuroscience.2025011. eCollection 2025.
2
Case Report: A case of gene-related early-onset Parkinson's disease and review of literature.病例报告:一例基因相关性早发型帕金森病及文献综述。
Front Neurosci. 2022 Dec 9;16:1064566. doi: 10.3389/fnins.2022.1064566. eCollection 2022.
3
3D Bioprinting Pluripotent Stem Cell Derived Neural Tissues Using a Novel Fibrin Bioink Containing Drug Releasing Microspheres.
使用含药物释放微球的新型纤维蛋白生物墨水3D生物打印多能干细胞衍生神经组织
Front Bioeng Biotechnol. 2020 Feb 11;8:57. doi: 10.3389/fbioe.2020.00057. eCollection 2020.
4
Azoramide protects iPSC-derived dopaminergic neurons with PLA2G6 D331Y mutation through restoring ER function and CREB signaling.阿佐酰胺通过恢复内质网功能和 CREB 信号来保护 PLA2G6 D331Y 突变诱导的 iPSC 衍生多巴胺能神经元。
Cell Death Dis. 2020 Feb 18;11(2):130. doi: 10.1038/s41419-020-2312-8.